The Centers for Medicare & Medicaid Services (CMS) has added 22 HCPCS codes in nine durable medical equipment (DME) ...

Application represents an important step in supporting reimbursement Company remains on track for U.S. commercial launch of LYTENAVA before ...

Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver ...

The Center for Medicare & Medicaid Services (CMS) issued the display copy of the final Calendar Year 2025 Physician Fee Schedule on November 1, 2024, which included three new Healthcare Common ...

The newsletter outlines key differences between off-the-shelf (OTS), custom fitted, and custom fabricated knee orthoses, which dictate HCPCS coding and billing for these items. Physician and ...

The amount Medicare pays per RVU gets its first substantial boost in years, but most of the increase will expire at the end of 2026 unless Congress acts. Editor's note: This article was updated to ...

ISELIN - Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA (bevacizumab-vikg, bevacizumab gamma) for the treatment of ...

Outlook Therapeutics, Inc. announced that it has submitted an application to the Centers for Medicare & Medicaid Services (CMS) requesting a permanent, product-specific Healthcare Common Procedure ...